ECL vs SHW vs APD
161 measures in 16 categories, one definition each, computed from filings and market data.
SHW62.2
The Sherwin-Williams Company
Basic Materials · Chemicals - Specialty
$335.20 −0.58%$81.4B mkt cap
Score DNA
APD30.9
Air Products and Chemicals, Inc.
Basic Materials · Chemicals - Specialty
$299.59 +0.96%$66.7B mkt cap
Score DNA
Price, rebased to 100 three years ago
ECL SHW APD · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Insider open-market buys, 180d | 6 | 0 | 0 |
| Insider $ bought, 180d | $3.74M | — | — |
| Congress purchases, 180d | 3 | 6 | 1 |
| Last Congress purchase | 2026-09-25 | 2026-09-25 | 2026-09-04 |
| 13F net change in holders | +17 | +47 | −9 |
| ETFs adding shares, 30d | 1,273 | 1,112 | 1,069 |
| ETFs trimming, 30d | 1,025 | 926 | 812 |
| Net ETF funds, 30d | +248 | +186 | +257 |
Valuation
16 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| P/E (TTM) | 38.3x
76th
|
30.3x
56th
|
— |
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.73
29th
|
4.78
86th
|
— |
| Price / sales | 4.8x
88th
|
3.3x
80th
|
5.3x
93rd
|
| Price / book | 8.1x
92nd
|
21.1x
98th
|
4.8x
80th
|
| Price / tangible book | — | — | 5.1x
48th
|
| Price / free cash flow | 43.2x
89th
|
25.3x
58th
|
32.4x
72nd
|
| Price / operating cash flow | 26.5x
90th
|
20.9x
78th
|
14.6x
62nd
|
| Enterprise value | $89.6B
95th
|
$95.3B
98th
|
$83.9B
93rd
|
| EV / sales | 5.3x
90th
|
3.9x
83rd
|
6.7x
93rd
|
| EV / EBITDA | 24.9x
89th
|
20.5x
80th
|
19.2x
71st
|
| EV / EBIT | 31.1x
80th
|
23.8x
53rd
|
29.6x
77th
|
| EV / free cash flow | 47.8x
78th
|
29.7x
50th
|
40.8x
72nd
|
| Earnings yield | 2.6%
55th
|
3.3%
67th
|
-0.1%
38th
|
| FCF yield | 2.3%
24th
|
3.9%
50th
|
3.1%
38th
|
| Operating cash flow yield | 3.8%
14th
|
4.8%
26th
|
6.9%
40th
|
| Graham number (per share) | $77.35
84th
|
$61.79
68th
|
— |
Profitability (TTM)
12 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Gross margin | 44.1%
90th
|
49.1%
95th
|
32.1%
57th
|
| EBITDA margin | 21.4%
88th
|
19.0%
73rd
|
34.7%
95th
|
| Operating margin | 17.4%
85th
|
16.4%
80th
|
-4.7%
10th
|
| EBIT margin | 17.1%
85th
|
16.4%
83rd
|
22.5%
95th
|
| Net margin | 12.6%
88th
|
11.0%
83rd
|
-0.4%
34th
|
| NOPAT margin | 14.1%
83rd
|
12.6%
78th
|
-3.7%
10th
|
| FCF margin | 11.1%
71st
|
13.2%
76th
|
16.3%
88th
|
| Operating cash flow margin | 18.1%
76th
|
15.9%
68th
|
36.3%
98th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.7%
54th
|
| SG&A / revenue | 26.0%
85th
|
32.6%
93rd
|
7.1%
20th
|
| Stock comp / revenue | 0.8%
73rd
|
0.5%
56th
|
0.4%
34th
|
| Effective tax rate | 18.9%
12th
|
23.0%
67th
|
21.0%
14th
|
Returns on capital
11 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| ROE (on average equity) | 21.8%
88th
|
65.1%
100th
|
-0.3%
34th
|
| ROA | 7.9%
79th
|
10.3%
93rd
|
-0.1%
36th
|
| ROIC | 12.7%
79th
|
17.3%
90th
|
-1.5%
19th
|
| ROCE | 12.0%
74th
|
23.1%
98th
|
7.9%
60th
|
| Return on tangible assets | 10.7%
76th
|
15.3%
90th
|
6.9%
60th
|
| Cash ROIC (OCF / invested capital) | 16.4%
69th
|
21.9%
86th
|
14.7%
60th
|
| Gross profitability (GP / assets) | 24.8%
81st
|
44.4%
98th
|
10.0%
17th
|
| ROIC, 3-yr average | 13.1%
90th
|
14.1%
92nd
|
3.8%
49th
|
| ROIC, 5-yr average | 14.0%
85th
|
16.0%
90th
|
7.4%
59th
|
| ROE, 5-yr average | 19.2%
84th
|
67.6%
100th
|
11.8%
61st
|
| Incremental ROIC | 11.6%
55th
|
124.0%
88th
|
92.2%
85th
|
Growth
17 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Revenue growth (TTM YoY) | 7.1%
63rd
|
5.8%
56th
|
4.5%
54th
|
| Revenue growth (QoQ) | 8.6%
31st
|
19.8%
74th
|
-0.3%
5th
|
| Revenue CAGR, 3 yr | 4.5%
77th
|
2.1%
64th
|
-1.0%
46th
|
| Revenue CAGR, 5 yr | 6.8%
68th
|
4.4%
50th
|
5.2%
61st
|
| Gross profit CAGR, 3 yr | 9.3%
85th
|
5.8%
72nd
|
2.7%
56th
|
| Operating income CAGR, 3 yr | 16.1%
82nd
|
5.4%
46th
|
— |
| Net income growth (TTM YoY) | -0.9%
33rd
|
5.6%
50th
|
— |
| Net income CAGR, 3 yr | 21.7%
91st
|
4.7%
36th
|
— |
| EPS growth (TTM YoY) | -0.0%
33rd
|
7.7%
50th
|
— |
| EPS CAGR, 3 yr | 22.2%
91st
|
6.3%
45th
|
— |
| EPS CAGR, 5 yr | 15.5%
83rd
|
6.1%
48th
|
— |
| FCF growth (TTM YoY) | 19.1%
56th
|
49.1%
81st
|
— |
| FCF CAGR, 3 yr | 12.2%
64th
|
22.4%
86th
|
— |
| Operating cash flow CAGR, 3 yr | 13.9%
74th
|
14.7%
77th
|
12.4%
69th
|
| Book value CAGR, 3 yr | 10.4%
77th
|
3.6%
54th
|
-0.6%
36th
|
| Dividend CAGR, 3 yr | 4.7%
84th
|
2.7%
62nd
|
0.4%
31st
|
| Sustainable growth rate | 13.6%
68th
|
46.1%
96th
|
— |
Margin history & stability
7 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Gross margin, 3-yr average | 43.6%
92nd
|
48.7%
95th
|
31.9%
62nd
|
| Operating margin, 3-yr average | 16.7%
85th
|
14.5%
80th
|
10.3%
50th
|
| Net margin, 3-yr average | 12.4%
90th
|
11.0%
85th
|
11.2%
88th
|
| FCF margin, 3-yr average | 11.5%
85th
|
10.9%
82nd
|
-14.2%
2nd
|
| Revenue stability (0-1) | 0.94
90th
|
0.86
78th
|
0.51
44th
|
| Earnings stability (0-1) | 0.90
90th
|
0.67
68th
|
0.45
54th
|
| Margin stability (0-1) | 0.95
78th
|
0.96
83rd
|
0.96
88th
|
Liquidity (latest quarter)
7 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Cash & short-term investments | $5.1B
100th
|
$293.5M
60th
|
$980.5M
83rd
|
| Net cash (− = net debt) | −$8.6B
10th
|
−$13.9B
5th
|
−$17.2B
2nd
|
| Working capital | $5.0B
100th
|
−$2.6B
0th
|
$388.2M
45th
|
| Current ratio | 1.84
50th
|
0.73
0th
|
1.08
10th
|
| Quick ratio | 1.57
69th
|
0.46
0th
|
0.92
21st
|
| Cash ratio (cash + ST investments / current liabilities) | 0.86
83rd
|
0.03
2nd
|
0.21
36th
|
| Defensive interval (days) | 696 days
61st
|
177 days
2nd
|
282 days
7th
|
Leverage & solvency (latest quarter)
13 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Total debt | $13.8B
90th
|
$14.2B
93rd
|
$18.2B
98th
|
| Debt / equity | 1.37
82nd
|
3.69
95th
|
1.31
75th
|
| Net debt / equity | 0.86
70th
|
3.61
95th
|
1.24
82nd
|
| Debt / assets | 46.0%
79th
|
52.7%
90th
|
44.9%
76th
|
| Debt / capital | 57.8%
82nd
|
78.7%
95th
|
56.7%
75th
|
| Debt / EBITDA | 3.82
57th
|
3.06
37th
|
4.15
66th
|
| Net debt / EBITDA | 2.39
34th
|
3.00
51st
|
3.92
71st
|
| Interest coverage (EBIT / interest) | 9.5x
78th
|
7.8x
72nd
|
12.8x
82nd
|
| Cash interest coverage | 10.1x
78th
|
7.5x
57th
|
20.7x
90th
|
| Debt payback (years of OCF) | 4.5 yrs
52nd
|
3.7 yrs
32nd
|
4.0 yrs
42nd
|
| Liabilities / assets | 66.3%
71st
|
85.7%
90th
|
59.0%
57th
|
| IS credit model rating | A | BBB+ | BBB |
| Implied credit spread (bps) | 150
21st
|
225
36th
|
275
40th
|
Efficiency
11 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Asset turnover | 0.63
40th
|
0.93
74th
|
0.31
7th
|
| Fixed asset turnover | 3.24
69th
|
3.89
83rd
|
0.49
2nd
|
| Inventory turnover | 5.9
71st
|
5.0
59th
|
11.1
93rd
|
| Receivables turnover | 5.2
24th
|
7.3
62nd
|
6.6
55th
|
| Days sales outstanding | 71 days
76th
|
50 days
38th
|
55 days
45th
|
| Days inventory outstanding | 62 days
29th
|
74 days
41st
|
33 days
7th
|
| Days payables outstanding | 78 days
83rd
|
79 days
86th
|
118 days
98th
|
| Cash conversion cycle (days) | 55 days
31st
|
44 days
19th
|
−30 days
2nd
|
| Capex / revenue | 7.0%
71st
|
2.8%
17th
|
19.9%
95th
|
| Capex / depreciation | 1.63
88th
|
1.05
61st
|
1.63
90th
|
| Operating expense ratio | 26.9%
76th
|
31.0%
78th
|
99.1%
95th
|
Cash flow & earnings quality
7 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Operating cash flow / net income | 1.44
48th
|
1.45
52nd
|
— |
| FCF / net income | 0.89
28th
|
1.20
60th
|
— |
| FCF / operating cash flow | 61.3%
51st
|
82.7%
95th
|
45.0%
23rd
|
| Capex / operating cash flow | 38.7%
49th
|
17.3%
5th
|
55.0%
77th
|
| Accruals ratio | -3.5%
74th
|
-4.6%
62nd
|
-11.2%
19th
|
| Sloan accruals ratio | 8.0%
95th
|
-5.7%
43rd
|
-6.2%
33rd
|
| Earnings quality score (0-1) | 1.00
40th
|
1.00
40th
|
— |
Scores & forensic checks
15 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| IS score | 58
74th
|
62
83rd
|
31
29th
|
| IS profitability | 59
88th
|
66
90th
|
10
21st
|
| IS growth | 45
39th
|
54
63rd
|
36
27th
|
| IS value | 37
21st
|
42
33rd
|
35
19th
|
| IS momentum | 74
63rd
|
77
68th
|
38
17th
|
| IS risk (safety) | 100
79th
|
90
71st
|
65
50th
|
| IS quality | 68
69th
|
58
43rd
|
39
14th
|
| IS balance sheet | 64
79th
|
30
19th
|
51
55th
|
| IS earnings quality | 72
67th
|
76
90th
|
39
10th
|
| IS cash flow | 60
76th
|
70
90th
|
43
36th
|
| Piotroski F-score (0-9) | 5
29th
|
6
52nd
|
5
29th
|
| Altman Z-score | 4.1
81st
|
3.6
71st
|
2.8
57th
|
| Beneish M-score | −2.52
73rd
|
−2.54
71st
|
−3.03
24th
|
| Ohlson O-score | −7.79
36th
|
−6.24
76th
|
−7.48
40th
|
| IS credit score | 74
76th
|
63
64th
|
60
60th
|
Size (TTM)
8 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| Market cap | $81.0B
95th
|
$81.4B
98th
|
$66.7B
93rd
|
| Revenue | $16.8B
93rd
|
$24.4B
95th
|
$12.6B
88th
|
| EBITDA | $3.6B
93rd
|
$4.6B
98th
|
$4.4B
95th
|
| Net income | $2.1B
95th
|
$2.7B
98th
|
−$47.3M
31st
|
| Free cash flow | $1.9B
88th
|
$3.2B
95th
|
$2.1B
93rd
|
| Total assets | $29.9B
93rd
|
$27.0B
90th
|
$40.4B
98th
|
| Shareholders' equity | $10.1B
88th
|
$3.9B
76th
|
$13.9B
95th
|
| Employees | 48,000
95th
|
64,249
98th
|
21,194
88th
|
Price performance
9 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| 1 day | −0.7% | −0.6% | +1.0% |
| 1 week | +2.5% | +4.9% | +6.5% |
| 1 month | +6.3% | +4.4% | +5.3% |
| 3 months | +7.5% | +3.5% | +0.9% |
| 6 months | +5.1% | −3.1% | +2.6% |
| Year to date | +9.9% | +2.4% | +19.6% |
| 1 year | +5.8% | +0.9% | +16.3% |
| 3 years, cumulative | +74.1% | +33.7% | +8.4% |
| 5 years, cumulative | +40.9% | +20.0% | +24.7% |
Technicals
4 measures| Measure | ECL | SHW | APD |
|---|---|---|---|
| RSI 14 | 63.3 | 58.4 | 65.9 |
| From 52-week high | −6.6% | −11.1% | −4.9% |
| From 52-week low | +18.8% | +15.6% | +30.7% |
| Beta | 0.88 | 1.08 | 0.76 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17